BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2270377)

  • 1. [Conservative therapy of peripheral arterial occlusive disease].
    Frauchiger B
    Schweiz Rundsch Med Prax; 1990 Dec; 79(50):1560-3. PubMed ID: 2270377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug therapy in peripheral arterial occlusive disease].
    Bollinger A
    Schweiz Med Wochenschr; 1988 Sep; 118(36):1283-9. PubMed ID: 3051339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of peripheral arterial occlusive disease with special reference to prostaglandins].
    Creutzig A
    Z Gesamte Inn Med; 1991 Mar; 46(3):59-67. PubMed ID: 1828125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment strategies in arterial occlusive diseases].
    Bollinger A
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1354-8. PubMed ID: 8272701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of peripheral arterial occlusive diseases. Round table conference].
    Bollinger A; Biland L; Brunner U; Kappert A; Krähenbühl B; Mahler F; Monti M; Nachbur B; Schneider E; Widmer LK
    Schweiz Med Wochenschr; 1983 Dec; 113(49):1834-6. PubMed ID: 6233698
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
    Lorenzen ND; Eldrup N; Laustsen J
    Ugeskr Laeger; 2007 Sep; 169(39):3279-82. PubMed ID: 17953885
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preventive drug therapy following coronary bypass surgery or PTCA].
    Lechleitner P; Genser N; Dienstl F
    Wien Med Wochenschr; 1990 Jun; 140(10-11):277-8, 281. PubMed ID: 2368420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis.
    Girolami B; Bernardi E; Prins MH; ten Cate JW; Prandoni P; Simioni P; Andreozzi GM; Girolami A; Büller HR
    Eur J Vasc Endovasc Surg; 2000 Apr; 19(4):370-80. PubMed ID: 10801370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Large trials in the secondary prevention of stroke].
    Gensini GF; Simone I; Pantoni L; Inzitari D
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():102S-109S. PubMed ID: 9004808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic agents after peripheral transluminal angioplasty: a review of the studies, methods and evidence for their use.
    Watson HR; Bergqvist D
    Eur J Vasc Endovasc Surg; 2000 May; 19(5):445-50. PubMed ID: 10828222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preventive treatment of cerebrovascular accidents of arterial origin].
    Castillo V; Bogousslavsky J; Vuadens P
    Praxis (Bern 1994); 1996 Feb; 85(6):159-63. PubMed ID: 8701178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of vasoactive drugs in conservative therapy of peripheral arterial occlusive disease].
    Scheffler A; Rieger H
    Z Arztl Fortbild Qualitatssich; 1999 Nov; 93(9):639-44. PubMed ID: 10666827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of platelet inhibitors on platelet uptake and restenosis after femoral angioplasty.
    Horrocks M; Horrocks EH; Murphy P; Lane IF; Ruttley MS; Fligelstone LJ; Watson HR
    Int Angiol; 1997 Jun; 16(2):101-6. PubMed ID: 9257670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern conservative therapy of arterial occlusive diseases].
    Schultz-Ehrenburg U
    Hautarzt; 1980 Aug; 31(8):419-27. PubMed ID: 7451147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy and behavioral intervention for peripheral arterial disease.
    Doyle J; Creager MA
    Rev Cardiovasc Med; 2003; 4(1):18-24. PubMed ID: 12684600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet function inhibition and anticoagulation in coronary, cerebral and peripheral arterial occlusive disease. 2. Secondary prevention].
    Marshall M
    Fortschr Med; 1982 May; 100(18):825-30. PubMed ID: 7095698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of antithrombotic agents in peripheral arterial diseases].
    Wütschert R; Bounameaux H
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1551-5. PubMed ID: 9092417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention].
    Böger RH; Bode-Böger SM; Alfke H
    Vasa; 1996; 25(1):21-31. PubMed ID: 8851262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?
    Halkes PH; Algra A
    Cerebrovasc Dis; 2007; 24 Suppl 1():107-11. PubMed ID: 17971645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.